Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity

Trillions of microbes in the human intestinal tract, including bacteria, viruses, fungi, and protozoa, are collectively referred to as the gut microbiome. Recent technological developments have led to a significant increase in our understanding of the human microbiome. It has been discovered that th...

Full description

Bibliographic Details
Main Authors: Kunika, Norbert Frey, Ashraf Y. Rangrez
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/8/7261
_version_ 1797605082401865728
author Kunika
Norbert Frey
Ashraf Y. Rangrez
author_facet Kunika
Norbert Frey
Ashraf Y. Rangrez
author_sort Kunika
collection DOAJ
description Trillions of microbes in the human intestinal tract, including bacteria, viruses, fungi, and protozoa, are collectively referred to as the gut microbiome. Recent technological developments have led to a significant increase in our understanding of the human microbiome. It has been discovered that the microbiome affects both health and the progression of diseases, including cancer and heart disease. Several studies have indicated that the gut microbiota may serve as a potential target in cancer therapy modulation, by enhancing the effectiveness of chemotherapy and/or immunotherapy. Moreover, altered microbiome composition has been linked to the long-term effects of cancer therapy; for example, the deleterious effects of chemotherapy on microbial diversity can, in turn, lead to acute dysbiosis and serious gastrointestinal toxicity. Specifically, the relationship between the microbiome and cardiac diseases in cancer patients following therapy is poorly understood. In this article, we provide a summary of the role of the microbiome in cancer treatment, while also speculating on a potential connection between treatment-related microbial changes and cardiotoxicity. Through a brief review of the literature, we further explore which bacterial families or genera were differentially affected in cancer treatment and cardiac disease. A deeper understanding of the link between the gut microbiome and cardiotoxicity caused by cancer treatment may help lower the risk of this critical and potentially fatal side effect.
first_indexed 2024-03-11T04:56:07Z
format Article
id doaj.art-6c8a0fce6f244088ab0eb63b6ce01cb4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:56:07Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6c8a0fce6f244088ab0eb63b6ce01cb42023-11-17T19:37:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01248726110.3390/ijms24087261Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced CardiotoxicityKunika0Norbert Frey1Ashraf Y. Rangrez2Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, 69120 Heidelberg, GermanyTrillions of microbes in the human intestinal tract, including bacteria, viruses, fungi, and protozoa, are collectively referred to as the gut microbiome. Recent technological developments have led to a significant increase in our understanding of the human microbiome. It has been discovered that the microbiome affects both health and the progression of diseases, including cancer and heart disease. Several studies have indicated that the gut microbiota may serve as a potential target in cancer therapy modulation, by enhancing the effectiveness of chemotherapy and/or immunotherapy. Moreover, altered microbiome composition has been linked to the long-term effects of cancer therapy; for example, the deleterious effects of chemotherapy on microbial diversity can, in turn, lead to acute dysbiosis and serious gastrointestinal toxicity. Specifically, the relationship between the microbiome and cardiac diseases in cancer patients following therapy is poorly understood. In this article, we provide a summary of the role of the microbiome in cancer treatment, while also speculating on a potential connection between treatment-related microbial changes and cardiotoxicity. Through a brief review of the literature, we further explore which bacterial families or genera were differentially affected in cancer treatment and cardiac disease. A deeper understanding of the link between the gut microbiome and cardiotoxicity caused by cancer treatment may help lower the risk of this critical and potentially fatal side effect.https://www.mdpi.com/1422-0067/24/8/7261gut microbiomedysbiosiscancer treatmentcardiotoxicity
spellingShingle Kunika
Norbert Frey
Ashraf Y. Rangrez
Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
International Journal of Molecular Sciences
gut microbiome
dysbiosis
cancer treatment
cardiotoxicity
title Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
title_full Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
title_fullStr Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
title_full_unstemmed Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
title_short Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
title_sort exploring the involvement of gut microbiota in cancer therapy induced cardiotoxicity
topic gut microbiome
dysbiosis
cancer treatment
cardiotoxicity
url https://www.mdpi.com/1422-0067/24/8/7261
work_keys_str_mv AT kunika exploringtheinvolvementofgutmicrobiotaincancertherapyinducedcardiotoxicity
AT norbertfrey exploringtheinvolvementofgutmicrobiotaincancertherapyinducedcardiotoxicity
AT ashrafyrangrez exploringtheinvolvementofgutmicrobiotaincancertherapyinducedcardiotoxicity